Cancer of Skin
11
2
3
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
18.2%
2 terminated out of 11 trials
60.0%
-26.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
A Mobile Health Intervention Among Hispanics
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Tempus Priority Study: A Pan-tumor Observational Study
Genomic Testing and Resulting Medical Decisions
A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin
A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma
Low-moderate Intensity Pedaling During Immunotherapy Administration
Computer Modelling to Plan Surgical Reconstruction
REO13 Melanoma With of Without GM-CSF
Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors
The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients